-+ 0.00%
-+ 0.00%
-+ 0.00%

Costco Stock Leads 3 Low Risk Picks For A More Resilient Portfolio

Simply Wall St·07/26/2026 10:23:48
Listen to the news

With energy and inflation risks back in focus, central banks moving at different speeds, and housing and labor data sending mixed signals, many investors are looking for stability that does not rely on perfect economic conditions. That is exactly what the Low-Risk Leaders screener aims to highlight: companies with resilient balance sheets and lower risk scores that can help form a sturdier core for your portfolio. Instead of chasing the latest story, you focus on strength and resilience. In this article, you will see 3 of the stocks from the Low-Risk Leaders screener that fit this foundation-building approach.

Neurocrine Biosciences (NBIX)

Overview: Neurocrine Biosciences is a US biopharmaceutical company that develops and commercializes treatments for neurological, psychiatric, endocrine, and immunological disorders, with key products like INGREZZA for movement disorders, Orilissa and Oriahnn for women’s health, and CRENESSITY for congenital adrenal hyperplasia.

Operations: Neurocrine Biosciences generates about US$3.1b in revenue from research, development, commercialization, and sale of pharmaceuticals, all currently reported from the United States.

Market Cap: US$17.7b

Neurocrine Biosciences appears in the Low-Risk Leaders screener because it already has meaningful neurology and endocrine franchises in INGREZZA and CRENESSITY, while also building a late stage central nervous system pipeline in areas like major depressive disorder, schizophrenia, and epilepsy. Earnings and revenue are forecast to grow, profit margins sit in the low 20% range, and recent leadership hires point to a company preparing to scale as a multi product biopharma. The flip side is significant, with heavy reliance on a few key drugs, rising pricing and reimbursement pressure, and higher commercial spending all posing risks to future earnings stability. Investors interested in how those trade offs develop may want to consider additional context on execution, valuation, and risk signals.

Neurocrine Biosciences’ established drug franchises and late stage pipeline could be pulling in different directions, so use the analyst forecasts to see how professionals are sizing up that tension in the analyst forecasts for Neurocrine Biosciences.

NasdaqGS:NBIX Earnings & Revenue Growth as at Jul 2026
NasdaqGS:NBIX Earnings & Revenue Growth as at Jul 2026

Vertiv Holdings Co (VRT)

Overview: Vertiv Holdings Co provides the power, cooling, and critical infrastructure that keeps data centers and communication networks running, especially for high-demand uses like artificial intelligence, e-commerce, online banking, and online gaming. Its hardware, software, and services help customers design, build, and maintain reliable, high-density digital facilities across the Americas, Asia Pacific, Europe, the Middle East, and Africa.

Operations: Vertiv generates about US$7.0b of revenue from the Americas, US$2.4b from Asia Pacific, and US$2.3b from Europe, the Middle East and Africa, with roughly US$1.0b eliminated as intersegment sales.

Market Cap: US$111.5b

Vertiv stands out in the Low-Risk Leaders screener because it sits at the heart of the AI buildout, supplying power and liquid cooling systems that are essential for high-density GPU data centers. It also reports high-quality earnings, strong margins, and a sizeable backlog around US$15b. Forecasts for earnings and revenue growth are described as robust, with improving profit margins and return on equity expected to reach very high levels. However, the stock trades on a premium P/E multiple and relies heavily on a small group of hyperscale customers, which can amplify any slowdown in orders. For investors, the key question is whether Vertiv’s AI-related demand, cash generation, and balance sheet strength can justify that premium over time and support its growth story.

Vertiv’s AI-fueled momentum and premium P/E raise a sharp question: are investors fully pricing the trade off between growth, cash generation, and concentration risk in the analyst forecasts for Vertiv Holdings Co?

NYSE:VRT P/E Ratio as at Jul 2026
NYSE:VRT P/E Ratio as at Jul 2026

Costco Wholesale (COST)

Overview: Costco Wholesale runs membership-only warehouse clubs across North America, Europe, Asia, and other international markets, selling a wide range of groceries, household goods, fuel, and services that are designed around low prices and high member loyalty.

Operations: Costco Wholesale generates about US$293.6b in revenue from its membership warehouse business, with roughly US$212.2b from the United States, US$39.7b from Canada, and US$41.8b from other international markets.

Market Cap: US$414.7b

Costco Wholesale attracts attention in a low risk context because it combines a sticky membership model, strong renewal rates, and high quality earnings with steady growth in areas such as China, digital retail, and retail media. Earnings are forecast to grow in the high single digits with return on equity projected to remain high. However, the stock trades on a rich P/E, so any disappointment in growth, tariffs on key categories, or pressure from rivals such as Sam’s Club could weigh on returns. For investors who care about durability but are wary of paying a premium, the tension between Costco’s wide moat and its valuation is a central consideration.

Costco’s high renewal rates and rich P/E suggest something powerful is happening beneath the headline growth. Use the analyst forecasts for Costco Wholesale to see whether the current premium is masking one crucial twist.

NasdaqGS:COST P/E Ratio as at Jul 2026
NasdaqGS:COST P/E Ratio as at Jul 2026

The three Low-Risk Leaders in this article are just a starting point. The full Low-Risk Leaders screener surfaces 76 more companies that share the same focus on resilience, balance sheet strength, and lower risk scores. Use Simply Wall St to identify and analyze the specific catalysts, cash flow profiles, and risk factors that matter most to you so you can build a higher conviction, foundation-first portfolio.

Take Control of Your Investment Journey

If Vertiv Holdings Co or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before They Fly?

Markets move fast, and the most interesting stocks often break out while everyone is still watching yesterday’s winners. Tap into fresh ideas that are under the radar for now and act early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.